NRXS
Neuraxis, Inc.
NYSE MKT: NRXS · HEALTHCARE · BIOTECHNOLOGY
$7.44
-2.23% today
Updated 2026-04-29
Market cap
$93.54M
P/E ratio
—
P/S ratio
26.21x
EPS (TTM)
$-0.95
Dividend yield
—
52W range
$2 – $8
Volume
0.2M
Neuraxis, Inc. (NRXS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-4.14M | $-2.23M | $-2.30M | $-6.69M | $-6.10M | $-6.43M |
| Capital expenditures | $27719.00 | $1390.00 | $61205.00 | $71781.00 | $27776.00 | $31150.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $48774.00 | $48641.00 | $27319.00 | $750000.00 | $1.40M | $596852.00 |
| Free cash flow | $-4.17M | $-2.24M | $-2.36M | $-6.77M | $-6.13M | $-6.46M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |